{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/medline-inc-class-a/","json":"https://alysly.com/json/markets/stocks/medline-inc-class-a/index.json","lang":"en-US","title":"Medline Inc. Class A (MDLN) Stock Price Today | US58507V1070","description":"Medline Inc. Class A (MDLN). Revenue $28.4bn, net margin 4.1% (FY ended Dec 2025). ISIN US58507V1070. Held in 16 ETFs (top 0.18% in XUHL).","modified":"2026-11-02T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/medline-inc-class-a/","json":"https://alysly.com/json/de/maerkte/aktien/medline-inc-class-a/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"Medline Inc. Class A","url":"https://alysly.com/markets/stocks/medline-inc-class-a/"}],"content":[{"type":"heading","level":1,"text":"Medline Inc. Class A (MDLN)"},{"type":"paragraph","text":"MDLN · Health Care · United States","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"United States","href":"https://alysly.com/markets/stocks/browse/?country=United%20States"}]},{"type":"paragraph","text":"Medline Inc. Class A (MDLN) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 0.18%. Anyone who holds an ETF containing Medline also has an indirect stake in the company."},{"type":"heading","level":2,"id":"data","text":"Data and Charts: Medline"},{"type":"heading","level":3,"text":"Key Data for Medline"},{"type":"facts","items":[{"label":"Held in","value":"16 ETFs"},{"label":"Highest weight","value":"0.18%"},{"label":"Indices","value":"7"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"United States"},{"label":"ISIN","value":"US58507V1070"}]},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":3,"text":"Medline Stock Price Chart"},{"type":"paragraph","text":"The Medline chart shows daily closing prices and is set to the current year by default. The stock is down 23.5% year to date. The last recorded close on October 30, 2026, was $32.12, at 3% of the 52-week range."},{"type":"paragraph","text":"Price series from our database since Dec 17, 2025, 219 daily values."},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"heading","level":3,"text":"Medline Stock Performance"},{"type":"table","caption":"Medline stock performance","rows":[["Year to date","-23.5%","1 year","–"],["1 month","-7.4%","3 months","-18.2%"]]},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"paragraph","text":"Measured in euros, Medline is down 19.6% year to date. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day."},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: Medline"},{"type":"heading","level":3,"text":"What ETF Is Medline In?"},{"type":"paragraph","text":"Medline has above-average ETF coverage and is held by 16 of the 104 ETFs we track, which together follow 7 indices. That puts the stock in more ETFs than 76.8% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"table","caption":"What ETF is Medline in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"XUHL / XUHC","links":[{"text":"XUHL","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-health-care-ucits-etf-1c/"}]},{"text":"MSCI USA Health Care","href":"https://alysly.com/markets/indices/msci-usa-health-care/"},"0.18%","€1.77"],[{"text":"XDWH","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-health-care-ucits-etf-1c/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.13%","€1.31"],[{"text":"SPFS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-health-care-ucits-etf/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.13%","€1.29"],[{"text":"SWWD","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-ucits-etf-dist/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.02%","€0.20"],[{"text":"SPPW","href":"https://alysly.com/markets/etfs/spdr-msci-world-ucits-etf/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.02%","€0.20"],[{"text":"XD9U / XD9D","links":[{"text":"XD9U","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-ucits-etf-1c/"}]},{"text":"MSCI USA","href":"https://alysly.com/markets/indices/msci-usa/"},"0.02%","€0.18"],[{"text":"XDWD / XDWL","links":[{"text":"XDWD","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ucits-etf-1c/"}]},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.01%","€0.13"],[{"text":"WIMI","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-imi-ucits-etf-1c/"},{"text":"MSCI World IMI","href":"https://alysly.com/markets/indices/msci-world-imi/"},"0.01%","€0.13"],[{"text":"SPYY","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-ucits-etf-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.01%","€0.11"],[{"text":"EUNL","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.01%","€0.10"],[{"text":"IUSQ","href":"https://alysly.com/markets/etfs/ishares-msci-acwi-ucits-etf-usd-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.01%","€0.10"],[{"text":"SPYI / SPSA","links":[{"text":"SPYI","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-investable-market-ucits-etf-acc/"}]},{"text":"MSCI ACWI IMI","href":"https://alysly.com/markets/indices/msci-acwi-imi/"},"< 0.01%","< €0.05"]]},{"type":"paragraph","text":"Data note 6","href":"#dn-6"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to Medline, based on each fund's latest holdings list."},{"type":"paragraph","text":"US-listed ETFs holding Medline (weight per latest SEC filing): ONEQ 0.06%, VTI 0.02%. These funds are registered in the US; retail investors in the EU usually cannot buy them.","links":[{"text":"ONEQ","href":"https://alysly.com/markets/etfs/us/oneq/"},{"text":"VTI","href":"https://alysly.com/markets/etfs/us/vti/"}]},{"type":"list","ordered":false,"items":[{"text":"Medline among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 16 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much Medline overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"Which Tracked Investors Hold Medline?"},{"type":"paragraph","text":"Medline is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. Of the 4 tracked managers holding the stock, 3 added and 1 cut.","links":[{"text":"GOOGL","href":"https://alysly.com/markets/stocks/alphabet-inc-class-a/"}]},{"type":"table","caption":"Tracked investors holding this stock","columns":["Investor","Shares","Value","Quarter"],"rows":[["Lone Pine Capital","20,968,367","$827M","increased by 9,179,211"],["Viking Global Investors","4,841,080","$191M","reduced by 6,592,912"],["Soros Fund Management","1,638,244","$65M","increased by 351,810"],["Bridgewater Associates","19,847","$782,766","newly added"]]},{"type":"paragraph","text":"As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains."},{"type":"paragraph","text":"Data note 7","href":"#dn-7"},{"type":"heading","level":3,"text":"What Medline Executives and Directors Traded Recently"},{"type":"table","caption":"Trades by executives and directors","columns":["Date","Person","Type","Shares","Price"],"rows":[["Oct 8, 2026","GIC Private Ltd 10% owner","Sell","7,816,987","$35.15"],["Oct 6, 2026","GIC Private Ltd 10% owner","Sell","7,183,013","$35.05"],["Oct 6, 2026","GIC Private Ltd 10% owner","Sell","2,088,987","$35.05"],["Oct 5, 2026","GIC Private Ltd 10% owner","Sell","1,688,690","$35.78"],["Oct 2, 2026","GIC Private Ltd 10% owner","Sell","7,146,941","$34.33"],["Oct 2, 2026","GIC Private Ltd 10% owner","Sell","2,570,999","$35.35"]]},{"type":"paragraph","text":"The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded."},{"type":"paragraph","text":"“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32."},{"type":"paragraph","text":"Data note 8","href":"#dn-8"},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to Medline"},{"type":"table","caption":"Stocks with ETF exposure similar to Medline","columns":["Stock","Shared ETFs","r","1 year","Annualized volatility","Net margin","Revenue growth"],"rows":[["Medline","–","–","–","43.8%","4.1%","+11.5%"],[{"text":"Insmed Incorporated","href":"https://alysly.com/markets/stocks/insmed-incorporated/"},"16","–","-42.0%","54.9%","-210.5%","+66.7%"],[{"text":"Natera","href":"https://alysly.com/markets/stocks/natera-inc/"},"16","–","+114.4%","46.7%","-9.0%","+35.9%"],[{"text":"Neurocrine Biosciences","href":"https://alysly.com/markets/stocks/neurocrine-biosciences-inc/"},"16","–","+5.8%","36.2%","16.7%","+21.4%"],[{"text":"Roivant Sciences","href":"https://alysly.com/markets/stocks/roivant-sciences-ltd/"},"16","–","+88.5%","39.4%","-3,629.2%","-71.6%"],[{"text":"Revolution Medicines","href":"https://alysly.com/markets/stocks/revolution-medicines-inc/"},"16","–","+225.0%","56.2%","–","–"],[{"text":"United Therapeutics Corporation","href":"https://alysly.com/markets/stocks/united-therapeutics-corporation/"},"16","–","+32.0%","41.2%","41.9%","+10.6%"],[{"text":"Royalty Pharma Plc","href":"https://alysly.com/markets/stocks/royalty-pharma-plc-class-a/"},"16","–","+81.9%","23.4%","32.4%","+5.1%"],[{"text":"Boston Scientific Corporation","href":"https://alysly.com/markets/stocks/boston-scientific-corporation/"},"16","–","-58.3%","30.9%","14.4%","+19.9%"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as Medline. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical."},{"type":"paragraph","text":"Data note 9","href":"#dn-9"},{"type":"heading","level":2,"id":"fundamental","text":"Fundamental Analysis: Medline"},{"type":"heading","level":3,"text":"Medline Key Financials"},{"type":"facts","items":[{"label":"Revenue","value":"$28.4B"},{"label":"Net income","value":"$1.2B"},{"label":"Diluted EPS","value":"-$0.01"},{"label":"Net margin","value":"4.1%"},{"label":"Gross margin","value":"26.4%"},{"label":"Return on equity","value":"10.8%"},{"label":"Equity ratio","value":"27.9%"},{"label":"Revenue growth","value":"+11.5%"}]},{"type":"paragraph","text":"Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025)."},{"type":"table","caption":"Revenue and profit by fiscal year","columns":["Fiscal year","Revenue","Net income","Margin"],"rows":[["FY ended Dec 2023","23.2","0.2","1.0%"],["FY ended Dec 2024","25.5","1.2","4.6%"],["FY ended Dec 2025","28.4","1.2","4.1%"]]},{"type":"paragraph","text":"Data note 10","href":"#dn-10"},{"type":"heading","level":2,"id":"technical","text":"Technical Analysis: Medline"},{"type":"heading","level":3,"text":"Medline Risk Metrics"},{"type":"facts","items":[{"label":"Max drawdown","value":"-36.7%"},{"label":"Annualized volatility","value":"43.8%"}]},{"type":"paragraph","text":"Data note 11","href":"#dn-11"},{"type":"facts","items":[{"label":"Below peak","value":"-35.7%"},{"label":"Beta to S&P 500","value":"0.57"},{"label":"Correlation to S&P 500","value":"0.17"}]},{"type":"paragraph","text":"The close on Oct 30, 2026, was 35.7% below the highest close since Dec 17, 2025. That high was reached on Feb 24, 2026. When the S&P 500 rose or fell 1%, Medline moved 0.57% on average in the same direction (past 218 trading days). The correlation of 0.17, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Medline."},{"type":"paragraph","text":"Data note 12","href":"#dn-12"},{"type":"heading","level":3,"text":"What Medline Correlates With"},{"type":"table","caption":"What Medline Correlates With","columns":["Instrument","r","−1 … +1"],"rows":[[{"text":"Insulet Corporation","href":"https://alysly.com/markets/stocks/insulet-corporation/"},"+0.50",""],[{"text":"Baxter International Inc.","href":"https://alysly.com/markets/stocks/baxter-international-inc/"},"+0.48",""],[{"text":"DaVita Inc.","href":"https://alysly.com/markets/stocks/davita-inc/"},"+0.48",""],[{"text":"Thomson Reuters Corporation","href":"https://alysly.com/markets/stocks/thomson-reuters-corporation/"},"+0.47",""],[{"text":"Align Technology Inc.","href":"https://alysly.com/markets/stocks/align-technology-inc/"},"+0.46",""],[{"text":"Henry Schein Inc.","href":"https://alysly.com/markets/stocks/henry-schein-inc/"},"+0.46",""],[{"text":"Brent crude oil","href":"https://alysly.com/markets/commodities/brent-crude/"},"-0.40",""],[{"text":"WTI crude oil","href":"https://alysly.com/markets/commodities/wti-crude/"},"-0.38",""],[{"text":"Targa Resources Corp.","href":"https://alysly.com/markets/stocks/targa-resources-corp/"},"-0.38",""]]},{"type":"paragraph","text":"The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio."},{"type":"paragraph","text":"Data note 13","href":"#dn-13"},{"type":"heading","level":2,"id":"refs","text":"Related Content: Medline"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 2, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-2","text":"Price history from daily closing prices; one point per trading day."},{"id":"dn-3","text":"Returns computed automatically from the price series, excluding dividends, taxes and costs."},{"id":"dn-4","text":"Daily dollar prices converted at the same day's ECB euro reference rate, then measured like the dollar return."},{"id":"dn-5","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-6","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-7","text":"Holdings as of quarter end from the mandatory filings (Form 13F) with the US securities regulator; the deadline runs up to 45 days."},{"id":"dn-8","text":"Purchases and sales by directors, officers and ten-percent owners from Form 4 filings with the US securities regulator, reported two trading days after the transaction."},{"id":"dn-9","text":"Selected by how many of the funds we track hold both names, not by business model."},{"id":"dn-10","text":"Latest reported fiscal year from XBRL annual filings with the SEC (public domain), figures in billions of US dollars; ratios computed from them."},{"id":"dn-11","text":"Computed from the full available price history."},{"id":"dn-12","text":"From daily closes: distance from the series' highest close; beta and correlation of daily returns to the S&P 500 over the last 252 trading days."},{"id":"dn-13","text":"Co-movement of daily returns over the last 90 trading days, across asset classes."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/medline-inc-class-a/#webpage","url":"https://alysly.com/markets/stocks/medline-inc-class-a/","name":"Medline Inc. Class A – Alysly","description":"Medline Inc. Class A (MDLN). Revenue $28.4bn, net margin 4.1% (FY ended Dec 2025). ISIN US58507V1070. Held in 16 ETFs (top 0.18% in XUHL).","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-02T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/medline-inc-class-a/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"Medline Inc. Class A"}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/medline-inc-class-a/#entity","name":"Medline Inc. Class A","tickerSymbol":"MDLN","url":"https://alysly.com/markets/stocks/medline-inc-class-a/","mainEntityOfPage":"https://alysly.com/markets/stocks/medline-inc-class-a/","description":"Medline Inc. Class A (MDLN). Revenue $28.4bn, net margin 4.1% (FY ended Dec 2025). ISIN US58507V1070. Held in 16 ETFs (top 0.18% in XUHL).","logo":"https://alysly.com/stock-logos/medline-logo.webp","image":"https://alysly.com/stock-logos/medline-logo.webp","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"MDLN"},{"@type":"PropertyValue","propertyID":"ISIN","value":"US58507V1070"}],"address":{"@type":"PostalAddress","addressCountry":"US"},"subjectOf":{"@type":"Dataset","name":"Medline Inc. Class A — key figures","url":"https://alysly.com/markets/stocks/medline-inc-class-a/","description":"Medline Inc. Class A (MDLN). Revenue $28.4bn, net margin 4.1% (FY ended Dec 2025). ISIN US58507V1070. Held in 16 ETFs (top 0.18% in XUHL).","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":16},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":0.1768},{"@type":"PropertyValue","name":"YTD return (%)","value":-23.5},{"@type":"PropertyValue","name":"Sector","value":"Health Care"},{"@type":"PropertyValue","name":"Revenue (USD)","unitText":"USD","value":28432000000.0},{"@type":"PropertyValue","name":"Net income (USD)","unitText":"USD","value":1159000000.0},{"@type":"PropertyValue","name":"Total assets (USD)","unitText":"USD","value":38484000000.0},{"@type":"PropertyValue","name":"Shareholders equity (USD)","unitText":"USD","value":10737000000.0},{"@type":"PropertyValue","name":"Diluted EPS (USD)","value":-0.01},{"@type":"PropertyValue","name":"Net margin (%)","value":4.1000000000000005},{"@type":"PropertyValue","name":"Return on equity (%)","value":10.8},{"@type":"PropertyValue","name":"Fiscal year end","value":"2025-12-31"}],"temporalCoverage":"2025-12-17/.."}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}